|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,097.00 ILa | +1.11% |
|
+2.91% | +0.27% |
| Market Cap | 125M 0 41.77M 36.52M 33.56M 31.28M 59.33M 3.98B 60.23M 403M 157M 1.95B 157M 153M 6.74B | P/E 2024 |
24.5x | P/E 2025 | -6.91x |
|---|---|---|---|---|---|
| Enterprise Value | 253M 0 84.47M 73.85M 67.86M 63.26M 120M 8.04B 122M 815M 317M 3.95B 317M 310M 13.62B | EV / Sales 2024 |
0.87x | EV / Sales 2025 | 0.84x |
| Free-Float |
17.21% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +1.11% | ||
| 1 week | +2.91% | ||
| Current month | +2.91% | ||
| 1 month | +2.72% | ||
| 3 months | -5.02% | ||
| 6 months | -0.09% | ||
| Current year | +0.27% |
| 1 week | 1,052 |  | 1,111 |
| 1 month | 1,006 | | 1,165 |
| Current year | 1,006 | | 1,348 |
| 1 year | 1,006 | | 1,348 |
| 3 years | 1,006 | | 1,887 |
| 5 years | 1,006 | | 2,670 |
| 10 years | 1,006 | | 4,076 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 82 | 1993-08-23 | |
Yuval Bernshtein
DFI | Director of Finance/CFO | 46 | 2018-10-31 |
| President | 80 | 2010-06-27 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 82 | 2010-06-24 | |
| Director/Board Member | 80 | - | |
Avraham Bigger
CHM | Chairman | 79 | 2015-04-14 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.11% | +2.91% | -14.30% | -33.19% | 41.77M | |
| +2.37% | +2.98% | +9.31% | +87.76% | 92.06B | |
| +0.51% | +0.43% | +44.87% | +152.50% | 55.96B | |
| +0.90% | +0.54% | -6.79% | +241.21% | 22.26B | |
| +1.26% | +5.43% | -10.09% | -24.85% | 8B | |
| +1.90% | +13.78% | -26.29% | -33.01% | 7.76B | |
| +1.89% | +6.02% | -9.61% | -28.77% | 6.66B | |
| -2.66% | +2.67% | +21.60% | +35.43% | 6.35B | |
| +0.17% | +0.88% | -2.65% | +21.43% | 5.36B | |
| +1.86% | +6.93% | -5.00% | -7.36% | 3.63B | |
| Average | +0.93% | +2.76% | +0.11% | +41.12% | 20.81B | |
| Weighted average by Cap. | +1.42% | +2.45% | +14.29% | +104.03% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 322M 0 107M 93.82M 86.22M 80.36M 152M 10.22B 155M 1.04B 402M 5.02B 403M 394M 17.31B | 301M 0 100M 87.77M 80.66M 75.19M 143M 9.56B 145M 968M 376M 4.7B 377M 369M 16.19B |
| Net income | 6.21M 0 2.07M 1.81M 1.66M 1.55M 2.94M 197M 2.98M 19.97M 7.76M 96.89M 7.77M 7.6M 334M | -18.07M -0 -6.03M -5.27M -4.84M -4.51M -8.56M -574M -8.69M -58.15M -22.61M -282M -22.63M -22.14M -972M |
| Net Debt | 127M 0 42.39M 37.06M 34.06M 31.75M 60.21M 4.04B 61.13M 409M 159M 1.98B 159M 156M 6.84B | 128M 0 42.7M 37.33M 34.31M 31.98M 60.65M 4.07B 61.57M 412M 160M 2B 160M 157M 6.89B |
Employees
390
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-03 | ILA 1,097.00 | +1.11% | 198 |
| 26-07-02 | ILA 1,085.00 | -0.82% | 2,223 |
| 26-07-01 | ILA 1,094.00 | +2.63% | 4,671 |
| 26-06-30 | ILA 1,066.00 | +1.43% | 3,924 |
| 26-06-29 | ILA 1,051.00 | -1.41% | 501 |
- Stock Market
- Stocks
- REKA Stock
Select your edition
All financial news and data tailored to specific country editions
